The Fellow on Call: The Heme/Onc Podcast
Episode 086: Prostate Cancer Series: Pt. 3- Surgical Approaches to Prostate Cancer
Dec 21, 2023
Dr. Sanjay Patel, a urologic oncologist, joins the hosts to discuss prostate cancer management. They cover topics such as determining biopsy candidacy, the role of MRI in diagnosis, steps involved in a biopsy, and when additional imaging is needed. They also explore surgical approaches, when pelvic lymph node dissection is recommended, and active surveillance. The podcast provides valuable insights into the management of localized prostate cancer.
00:00
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Active surveillance is recommended for low risk or favorable intermediate risk prostate cancer patients, involving close monitoring and regular biopsies.
- For high risk or very high risk localized prostate cancer, radiation therapy with hormonal therapy may be recommended, and additional treatments like abiraterone, prednisone, and radiation therapy might be considered.
Deep dives
Active Surveillance for Low-Intermediate Risk Prostate Cancer
Active surveillance is recommended for patients with low risk or favorable intermediate risk prostate cancer. It involves close monitoring every 3-6 months with PSA tests and digital rectal exams. Confirmatory biopsies are done within 6-12 months. MRI scans may be done every 3 years to assess prostate health. The frequency of biopsies and follow-up varies depending on each patient's individual situation and preferences.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
